Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 45
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Helicobacter ; 25(6): e12757, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-32939900

RESUMEN

BACKGROUND: Eradication rates of Helicobacter pylori (H pylori) with standard triple therapy are gradually decreasing all over the world, including in children, due to the development of strains resistant to antimicrobials. Sequential therapy can be used as an alternative method to increase eradication rates. MATERIALS AND METHODS: A total of 75 patients ≥ 8 years of age with H pylori gastritis were included in the study. According to Rome IV criteria, 38 patients had functional abdominal pain and dyspepsia, and 37 patients had alarm findings suggesting organic disease. Patients were treated with a novel sequential therapy consisting of the proton pump inhibitor (PPI)-lansoprazole (1 mg/kg/day, maximum 30 mg daily), amoxicillin (50 mg/kg/d in two doses, maximum 2 × 1000 mg) for 7 days followed by PPI-lansoprazole (1 mg/kg/d, maximum 30 mg daily), metronidazole (20 mg/kg/day in two doses, maximum 2 x 500 mg), tetracycline (50 mg/kg/d divided into four equal doses, maximum 4 x 500 mg), and bismuth subsalicylate (262 mg QID in patients ≤ 10 years of age, 524 mg QID in patients > 10 years of age in days 8-14). Eradication status was evaluated by H pylori stool antigen test 8 weeks after the completion of treatment. RESULTS: The mean age of the patients was 15.1 ± 2.4 years and 51 (68%) were female. No patient discontinued therapy due to side effects. All patients had antral gastritis (76.0%) or pangastritis (24.0%). The peptic ulcer rate was 6.6%. Eradication therapy was given to all patients with or without peptic ulcer. H pylori eradication was achieved in 69 (92.0%) patients and symptoms improved in 61 of those eradicated. CONCLUSIONS: As a first-line treatment for H pylori eradication in children, administering a novel sequential therapy including bismuth for 14 days provides a high rate of eradication.


Asunto(s)
Antibacterianos , Bismuto , Infecciones por Helicobacter , Adolescente , Amoxicilina/uso terapéutico , Antibacterianos/uso terapéutico , Bismuto/uso terapéutico , Niño , Claritromicina/uso terapéutico , Quimioterapia Combinada , Femenino , Infecciones por Helicobacter/tratamiento farmacológico , Helicobacter pylori , Humanos , Metronidazol/uso terapéutico , Resultado del Tratamiento , Turquía
2.
Ann Diagn Pathol ; 20: 44-7, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26616722

RESUMEN

The intercellular bridges are essential structures in maintaining the histologic organization of the epithelium, while providing a very efficient way to exchange molecules between cells and transduction of the cell-to-cell and matrix-to-cell signals. Derangement in those important structures' physical integrity and/or function, which can be assessed by the presence or absence of several intercellular bridge proteins including claudin-4, E-cadherin, and ß-catenin, was found to be related to several phenomena in the path to the neoplastic transformation. However, these proteins have not been studied in the wide variety of the skin neoplasms, in detail. Herein, we immunohistochemically assessed the expression patterns of these 3 intercellular bridge proteins on a total of 86 epidermal and eccrine adnexal tumors including basal cell carcinoma, squamous cell carcinoma, poroma, spiradenoma, syringoma, and hidradenoma. We observed a selective and distinct claudin-4 expression in the ductal-type cells of all cases of spiradenomas. Similarly, in the poromas, syringomas, and hidradenomas, claudin-4 was only positive in the luminal cells of microcystic structures, although not as conspicuous as in the spiradenomas. On the other hand, E-cadherin and ß-catenin were positive in almost all types of the tumors, in a way which was not contributory to differentiate from each other. In conclusion, we think that claudin-4 can be helpful at least in making a reliable differential diagnosis of spiradenoma when overlapping morphologic features do not allow to further subclassification in the overwhelming variety of the adnexal tumors.


Asunto(s)
Biomarcadores de Tumor/análisis , Claudina-4/biosíntesis , Neoplasias de Anexos y Apéndices de Piel/diagnóstico , Neoplasias Cutáneas/diagnóstico , Claudina-4/análisis , Humanos , Inmunohistoquímica , Neoplasias de Anexos y Apéndices de Piel/metabolismo , Estudios Retrospectivos , Neoplasias Cutáneas/metabolismo
3.
Ann Plast Surg ; 74(5): 615-20, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25710554

RESUMEN

BACKGROUND: Free fat grafts have an unpredictable survival rate that limits their successful use. To increase the viability of fat grafts, it is important to minimize the reabsorption rate. OBJECTIVE: Our aim was to investigate whether the combined use of platelet-rich plasma (PRP) and adipose derived stem cells (ADSCs) would contribute an improvement in lower resorption rates of fat grafts. METHODS: Inbred Fischer 344 rats were randomized into 4 groups (n = 10). Fat grafts were mixed with Dulbecco modified Eagle medium in group A, with PRP in group B, with ADSC in group C, and with PRP + ADSC in group D and were injected to the scalp.In vitro growth factor (vascular endothelial growth factor, transforming growth factor-ß, and fibroblast growth factor) levels were compared using enzyme-linked immunoassay method. After 12 weeks weight, volume and histology of the transplants were evaluated. RESULTS: The mean weight and volume of the fat grafts were highest in group D. Histopathological investigations revealed that the number of viable adipocytes and blood vessels were highest in group D. The level of growth factors was significantly higher in stem cell plus PRP group. CONCLUSION: Adipose-derived stem cells combined with PRP can enhance the survival of transplanted fat tissue.


Asunto(s)
Tejido Adiposo/trasplante , Supervivencia de Injerto , Trasplante de Células Madre Mesenquimatosas , Plasma Rico en Plaquetas , Animales , Distribución Aleatoria , Ratas , Ratas Endogámicas F344
4.
Neurol Neurochir Pol ; 49(4): 212-6, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26188936

RESUMEN

BACKGROUND: There are scarce data regarding the significance of the tumor size, hormonal activity and size of the pituitary tumor of the young; therefore, the study was designed to define the relation of the hormonal status of the large pituitary adenomas. OBJECTIVE: We compared those features with tumors of the elderly (>40) with the young patients, and analyzed the clinicopathologic and proliferative features of pituitary macroadenomas in young adulthood (≤40). METHODS: 20-year archives of pituitary tumors in our clinics were reviewed and macroadenomas with diameter≥3 cm were included in the study. We identified 46 pituitary adenomas and immunohistochemically stained them with pituitary hormones, p53 and Ki-67. Twenty-four cases were ≤40-year with an age range of 11-40 years (mean 28.0). Twenty-two cases were >40 with an age range of 44-78 years (mean 58.8). RESULTS: In the young patient group, 15 (62.5%) were functional adenomas (6 prolactinomas, six growth hormone [GH], one adrenocorticotrophic hormone [ACTH] adenoma, two multihormonal [GH+ACTH]) and nine (37.5%) were either gonadotrophic or null cell adenomas. In the elderly group, five (22.7%) were functional adenomas (two adrenocorticotrophic hormone [ACTH] adenoma, one prolactinoma, one growth hormone [GH], one multihormonal [GH+ACTH]) and 17 (77.3%) were either gonadotrophic or null cell adenomas. Ki-67 proliferation index in adenomas of the young was approximately two-folds higher than the elderly (2.7% vs. 1.2%). CONCLUSION: In both groups, rare p53 positivity was identified. In conclusion, pituitary macroadenomas of the young show hormonal expression frequently with relatively high Ki-67 proliferation indices.


Asunto(s)
Adenoma/patología , Neoplasias Hipofisarias/patología , Adolescente , Adulto , Factores de Edad , Anciano , Niño , Femenino , Humanos , Antígeno Ki-67/metabolismo , Masculino , Persona de Mediana Edad , Proteína p53 Supresora de Tumor/metabolismo , Adulto Joven
5.
J Surg Oncol ; 109(2): 71-4, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24165913

RESUMEN

BACKGROUND: A number of different therapies, including endoscopic resection, have been suggested for the treatment of Type 1 gastric neuroendocrine tumors (NETs). The current study aimed to determine the long-term efficacy of endoscopic resection for Type 1 gastric NETs. METHODS: Twenty-two patients (from 1999 to 2012) with Type 1 gastric NETs were included in the study. All patients were treated with endoscopic resection and received regular followed-up appointments at a tertiary referral center. RESULTS: All patients were initially diagnosed with hypergastrinemia, atrophic gastritis and intestinal metaplasia. Polyps' diameters were >1 cm in 4 patients, and between 0.5 and 1 cm in 18 patients. All detectable lesions were successfully resected. One patient required surgery due to gastric perforation during endoscopic mucosal resection. Recurrence was detected in four patients (18%) and endoscopic resection was performed again. Local or distant metastasis was not observed in any patient during follow-up. Median follow-up time was 7 years, with a maximum of 14 years. Seventeen patients (78%) completed a 5-year follow-up period, and overall disease-free survival rate was 100%. CONCLUSIONS: Long-term follow-ups with 22 patients suggest that endoscopic resection of Type 1 gastric NETs is a safe and effective treatment option with a relatively low recurrence rate.


Asunto(s)
Gastroscopía , Tumores Neuroendocrinos/cirugía , Pólipos/cirugía , Neoplasias Gástricas/cirugía , Adulto , Anciano , Cromogranina A/sangre , Supervivencia sin Enfermedad , Femenino , Estudios de Seguimiento , Mucosa Gástrica/cirugía , Gastrinas/sangre , Humanos , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia , Tumores Neuroendocrinos/clasificación , Tumores Neuroendocrinos/mortalidad , Tumores Neuroendocrinos/patología , Pólipos/patología , Estudios Prospectivos , Reoperación , Neoplasias Gástricas/mortalidad , Neoplasias Gástricas/patología
6.
J Magn Reson Imaging ; 37(5): 1077-82, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23148044

RESUMEN

PURPOSE: To evaluate the role of diffusion-weighted magnetic resonance imaging (DWMRI) in differentiating benign and malignant thyroid nodules using a 3 Tesla (T) MRI scanner. MATERIALS AND METHODS: Twenty-eight nodules in 25 patients and 14 healthy control cases were included in the study. DWMRI was acquired with 6 b values with a 3T MRI scanner. The apparent diffusion coefficient (ADC) values of the nodules were calculated from reconstructed ADC map images and were compared with the final histopathological diagnoses. RESULTS: The mean ADC value of the benign nodules was 1548 ± 353.4 (×10(-6) mm(2) /s), and the mean ADC of the malignant nodules was 814 ± 177.12 (×10(-6) mm(2) /s). The normal thyroid tissue had a mean ADC value of 1323.43 ± 210.35 × 10(-6) mm(2) /s (958-1689 × 10(-6) mm(2) /s) in the healthy control group. The ADC values were significantly different among the three groups (P = 0.001). An ADC value of 905 × 10(-6) mm(2) /s was determined to be the cutoff value for differentiating benign and malignant nodules, with 90% (55.5-98.3) sensitivity and 100% (81.3-100.0) specificity. CONCLUSION: This study suggests that the ADC values of nodules measured with a 3T MRI scanner could help in differentiating benign thyroid nodules from malignant nodules.


Asunto(s)
Algoritmos , Interpretación de Imagen Asistida por Computador/métodos , Imagen por Resonancia Magnética/métodos , Nódulo Tiroideo/patología , Adulto , Anciano , Diagnóstico Diferencial , Femenino , Humanos , Aumento de la Imagen/métodos , Masculino , Persona de Mediana Edad , Proyectos Piloto , Reproducibilidad de los Resultados , Sensibilidad y Especificidad
7.
J Clin Gastroenterol ; 47(6): 509-14, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23090042

RESUMEN

BACKGROUND: Mutations in the KRAS gene occur at an early stage in the development of colorectal carcinoma. Importantly, KRAS mutation predicts resistance to anti-epidermal growth factor receptor therapy in stage IV disease. GOALS: The aim of the current study is to correlate histologic features of colon cancer with the presence of KRAS mutations. STUDY: Tumor tissue from 145 colon cancer resections was tested for KRAS mutations. KRAS mutation status was correlated with demographic and histologic characteristics. Statistical analysis was performed using the Pearson χ2 test and multivariate analysis. RESULTS: KRAS mutations were present in 55/145 cases (37.9%), consistent with reported rates. KRAS mutations were significantly associated with usual adenocarcinoma morphology (multivariate P=0.014), peritumoral lymphocytic response (χ2, P=0.028; multivariate P=0.017), T3-T4 status (χ2, P=0.012; multivariate P=0.015), right-sided location (multivariate P=0.027), absence of lymphovascular invasion (multivariate P=0.008), and metastases at the time of resection (multivariate P=0.034). No association was found between KRAS mutation status and other factors. CONCLUSIONS: Specific morphologic features in colon cancer suggest a higher likelihood of the presence of KRAS mutations. These morphologic features overlap partially with those associated with DNA mismatch repair gene mutations. If confirmed, these results may suggest a paradigm for directed KRAS testing.


Asunto(s)
Adenocarcinoma/genética , Adenocarcinoma/patología , Mutación , Proteínas Proto-Oncogénicas/genética , Proteínas ras/genética , Adulto , Neoplasias del Colon/genética , Neoplasias del Colon/patología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Proteínas Proto-Oncogénicas p21(ras) , Estudios Retrospectivos
8.
Ann Diagn Pathol ; 17(6): 536-9, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23806202

RESUMEN

The number of mitotic figures in a predefined area is essential in pathologic evaluation for most tumors. This information sometimes provides clues in differentiating neoplastic lesions from nonneoplastic ones and sometimes in defining and grading of the tumors as well as prognosticating expected lifetime of the patient. As a generally accepted concept, scanning a certain number of consecutive nonoverlapping areas that are rich in viable tumor cells is required. Invasion fronts or the periphery of the tumors is preferred for counting mitosis. The target area to be counted for mitotic activity for various tumors is standardized as the number of mitosis in an established number of high-power fields. However, suggested mitotic counts, which constitute the basis of these studies, were obtained via the old microscopes, which usually had narrower visual fields than the state-of-the-art microscopes. Because the visual fields of the present microscopes provide larger areas compared with the older ones, corrections in mitosis counting are needed to make them compatible with the criteria, which had been put forward in the original reference studies.


Asunto(s)
Microscopía/métodos , Mitosis , Índice Mitótico/métodos , Neoplasias/patología , Patología Quirúrgica/métodos , Humanos , Microscopía/normas , Índice Mitótico/normas , Clasificación del Tumor , Patología Quirúrgica/instrumentación , Patología Quirúrgica/normas , Pronóstico , Reproducibilidad de los Resultados , Campos Visuales
9.
J Clin Ultrasound ; 41(7): 415-23, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23712620

RESUMEN

Fat necrosis (FN) of the breast is a benign nonsuppurative inflammatory process of the adipose tissue. The radiologic appearance ranges from benign to suspicious for malignancy; therefore, it is very important to know the distinguishing radiologic features of FN on different modalities. Mammography is more helpful in identifying FN than ultrasonography in most of the cases, and MRI may also be used to rule out malignancy as an adjunct to mammography and sonography. Even when modern diagnostic modalities are used, biopsy may still be unavoidable for some cases. In conclusion, an accurate history and familiarity with the radiologic findings are crucial to recognizing FN and avoiding unnecessary interventions.


Asunto(s)
Enfermedades de la Mama/diagnóstico por imagen , Necrosis Grasa/diagnóstico por imagen , Ultrasonografía Mamaria , Enfermedades de la Mama/diagnóstico , Enfermedades de la Mama/terapia , Necrosis Grasa/diagnóstico , Necrosis Grasa/terapia , Femenino , Humanos , Imagen por Resonancia Magnética , Mamografía
10.
Artículo en Inglés | MEDLINE | ID: mdl-37522564

RESUMEN

BACKGROUND/AIM: Gastric carcinoma (GC) is a highly heterogeneous disease with many subtypes that have different morphologic and molecular characteristics. In the current study, we analyzed immunohistochemical (IHC) and in situ hybridization (ISH) features of GCs and evaluated their association with prognosis and clinicopathological features. MATERIALS AND METHODS: Three hundred cases analyzed by IHC and ISH for microsatellite stability, p53, e-cadherin, HER2, PD-L1 expression, and Epstein-Barr virus (EBV) status. Cases were classified into five subgroups based on expression profile. The relationships between subgroups, clinicopathological features, and survival were determined. RESULTS: Ten (3.3%) cases were classified as EBV-associated, 45 (15%) as microsatellite instable (MSI), 73 (24.3%) as EBV-/microsatellite-stable (MSS)/epithelial-mesenchymal-transformation (EMT)-like, 75 (25%) as EBV-/MSS/ non-EMT-like/p53+, and 97 (32.3%) as EBV-/MSS/non-EMT-like/p53-. The MSI subtype had the best overall survival (OS). In contrast, the EBV-/MSS/EMT-like subtype had the poorest OS. The MSI subtype was also related with old age of the patient and antrum-corpus localized tumors, whereas the EBV-/MSS/EMT-like was associated with young age, larger tumor size, and advanced stage presentation. PD-L1 positivity is highly correlated with MSI and EBV-associated subtypes. CONCLUSION: Our data demonstrated a link between IHC/ISH characteristics of GC and clinical outcomes. IHC/ISH based molecular classification may be helpful in predicting the survival.


Asunto(s)
Carcinoma , Infecciones por Virus de Epstein-Barr , Neoplasias Gástricas , Humanos , Infecciones por Virus de Epstein-Barr/diagnóstico , Infecciones por Virus de Epstein-Barr/genética , Infecciones por Virus de Epstein-Barr/complicaciones , Herpesvirus Humano 4/genética , Herpesvirus Humano 4/metabolismo , Antígeno B7-H1/genética , Antígeno B7-H1/metabolismo , Pronóstico , Inmunohistoquímica , Proteína p53 Supresora de Tumor/genética , Inestabilidad de Microsatélites , Neoplasias Gástricas/diagnóstico , Neoplasias Gástricas/genética , Hibridación in Situ , Carcinoma/complicaciones
11.
Helicobacter ; 17(6): 486-90, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23067136

RESUMEN

BACKGROUND: Eradication rates of Helicobacter pylori with standard triple therapy are not satisfactory. Sequential therapy is an alternative method to overcome this problem. OBJECTIVES: The aim of this study was to assess efficacy of a modified sequential therapy with the addition of a bismuth preparation, as first-line treatment in the eradication of H. pylori infection. MATERIALS AND METHODS: One hundred and forty-two H. pylori-positive patients were included in the study. Patients were given a 14-day sequential therapy program consisting of pantoprazole, 40 mg (b.i.d. for 14 days); colloidal bismuth subcitrate, 300 mg 4 (two tablets before breakfast and dinner, for 14 days); amoxicillin, 1 g (b.i.d.for the first 7 days); tetracycline, 500 mg (q.i.d. for the second 7 days); and metronidazole, 500 mg (t.i.d. for the second 7 days). Eradication was tested by urea breath test (UBT) 6 weeks after completion of treatment. RESULTS: Of the 142 patients included, 131 completed the study. "Per-protocol" and "intention-to-treat" analyses revealed high eradication rates in this group (92.0-95% CI, 87.2-96.8%, and 81.0-95% CI, 74.5-87.4%, respectively). There was no relation to sex and age with this modified sequential therapy. Compliance was satisfactory (11 patients - four women and seven men were unavailable for follow-up), and side effects were minimal (six patients had to stop treatment - metronidazole-related facial swelling and numbness on the face and hands in two patients; tetracycline-related fever and epigastric pain and nausea and vomiting in two patients; and amoxicillin-related diarrhea and vaginal discharge in two patients). These side effects were reversible and resolved after the cessation of the related medication. CONCLUSIONS: This 14-day modified sequential treatment, including bismuth, achieves a significantly high eradication rates in patients with H. pylori infection, with five satisfactory patient compliance and minor side effects.


Asunto(s)
Antibacterianos/administración & dosificación , Infecciones por Helicobacter/tratamiento farmacológico , Compuestos Organometálicos/administración & dosificación , Adulto , Antibacterianos/efectos adversos , Pruebas Respiratorias , Quimioterapia Combinada/efectos adversos , Quimioterapia Combinada/métodos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Compuestos Organometálicos/efectos adversos , Estudios Prospectivos , Resultado del Tratamiento , Turquía , Urea/análisis
12.
J Gastrointestin Liver Dis ; 31(2): 163-167, 2022 06 12.
Artículo en Inglés | MEDLINE | ID: mdl-35574618

RESUMEN

BACKGROUND AND AIMS: Despite the known risk factors, it is not clear why the same treatment protocol for Helicobacter pylori infection (H. pylori) doesnot show a similar effect in patients with common risk factors. We hypothesized that as the severity of H. pylori - induced gastric mucosa inflammation and density increase, the rate of successful treatment decreases. This study aimed to explore the existence of a possible association between gastric H. pylori colonization density and the efficacy of bismuth-containing quadruple eradication therapy. METHODS: A total of 330 patients with H. pylori positive gastritis were initially included; the diagnosis was based on the histopathological examination. H. pylori colonization density was graded according to the Sydney classification: mild (n=101), moderate (104) and severe (98). H. pylori eradication was determined via the 13C-Urea breath test performed eight weeks after therapy. RESULTS: There was no significant difference in terms of the distributions of age, gender, alcohol consumption, and smoking status among the groups (p>0.05). The successful eradication rates of H. pylori were 87.1%, 78.8%, and 75.5%, respectively, for the mild, moderate, and severe H. pylori colonization groups by per-protocol analysis (p=0.038). The eradication rates of H. pylori were 81.5%, 73.2%, and 67.3% respectively, for the mild, moderate, and severe H. pylori colonization groups by intention-to-treat analysis (p=0.017). CONCLUSIONS: Helicobacter pylori colonization severity might predict the usefulness of eradication therapy in pre-treatment assessment. We recommend the use of more effective therapy regimens for H. pylori eradication in patients with severe densities.


Asunto(s)
Gastritis , Infecciones por Helicobacter , Helicobacter pylori , Amoxicilina , Antibacterianos/efectos adversos , Pruebas Respiratorias , Quimioterapia Combinada , Gastritis/diagnóstico , Gastritis/tratamiento farmacológico , Infecciones por Helicobacter/diagnóstico , Infecciones por Helicobacter/tratamiento farmacológico , Humanos , Factores de Riesgo , Resultado del Tratamiento
13.
Tumori ; 96(2): 352-4, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20572600

RESUMEN

Meningeal carcinomatosis (MC) is a rare presentation of solid tumors, particularly breast cancer, lung cancer, and malignant melanoma. Recently, the incidence of MC has been reported to be increasing. It has a bad prognosis despite aggressive therapy. The usual clinical presentation is multifocal involvement of the neuraxis, with headache and radicular pain being the most common initial symptoms. The most frequent signs are motor deficits, altered mental status, and cranial nerve involvement. The treatment of MC remains controversial and no straightforward guidelines exist in the literature. MC from urinary bladder tumors is rare. In this case report, we present a 52-year-old male patient with meningeal metastasis from a primary urinary bladder carcinoma along with a review of the related literature. Free full text available at www.tumorionline.it


Asunto(s)
Neoplasias Meníngeas/secundario , Neoplasias de la Vejiga Urinaria/patología , Humanos , Masculino , Persona de Mediana Edad
14.
J Craniofac Surg ; 21(2): 483-8, 2010 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-20216450

RESUMEN

Surgical treatment of calvarial defects and deformities has some drawbacks such as donor site morbidity or use of allogenic materials. In this experimental study, we presented a three-dimensional reconstruction of cranial defects by using trifocal biplanar distraction-compression osteosynthesis (TBDCO).Eight sheep with a mean age of 2 years were divided into 2 groups as the control (n = 3) and distraction groups (n = 5). All the animals were operated on under general anesthesia, and 80 x 50-mm full-thickness calvarial defects were created. In the control group, no treatment was performed. In the distraction group, TBDCO was performed with a custom-made distraction device with 2 transport segments. After 5 days of latency period, the anterior transport segment was distracted to a posterior and superior direction (0.7 and 0.3 mm, respectively) and the posterior transport segment was distracted obliquely to an anterior and superior direction (0.7 and 0.3 mm, respectively) with a resulting total vectorial movement of 0.75 mm/d. Active distraction was approximately 29 days, and the consolidation period was 60 days.No major complications were seen during the whole procedure. In the control group, the bone defects remained unhealed. In the distraction group, defects healed and the reconstructed calvarium was dome shaped. Preoperative and postoperative cranial volume measurements of the distraction group animals revealed an increase in cranial volume (P < 0.05). Histologic evaluation showed inductive bone regeneration and mature bone structure development within the distraction zone. Trifocal biplanar distraction-compression osteosynthesis is an effective and safe technique for three-dimensional closure of the cranial defects. In clinical practice, it could provide several advantages over currently available reconstructive procedures.


Asunto(s)
Enfermedades Óseas/cirugía , Craneotomía/métodos , Osteogénesis por Distracción/métodos , Hueso Parietal/cirugía , Procedimientos de Cirugía Plástica/métodos , Anatomía Transversal , Animales , Desarrollo Óseo/fisiología , Clavos Ortopédicos , Placas Óseas , Regeneración Ósea/fisiología , Calcificación Fisiológica/fisiología , Cefalometría/métodos , Diseño de Equipo , Fijadores Externos , Estudios de Factibilidad , Femenino , Procesamiento de Imagen Asistido por Computador , Imagenología Tridimensional/métodos , Osteogénesis por Distracción/instrumentación , Hueso Parietal/patología , Procedimientos de Cirugía Plástica/instrumentación , Ovinos , Tomografía Computarizada por Rayos X , Cicatrización de Heridas/fisiología
15.
Turk J Pediatr ; 62(4): 694-699, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32779428

RESUMEN

BACKGROUND: This report aims to discuss the mechanism of pleural and pericardial effusion related to mifamurtide which is an immunological agent used as adjuvant chemotherapy in osteosarcoma. CASE: Mifamurtide (2 mg/m < sup > 2 < /sup > ) and European and American Osteosarcoma Studies (EURAMOS) protocol were used together intravenously after complete surgical resection. No side effects occurred except for fever after the first dose. However, pleural, pericardial effusion, and splenic nodule formation began 11 months after discontinuation of mifamurtide treatment. Pleural biopsy revealed a type 4 hypersensitivity reaction. We treated the patient with 1,5 mg per day colchicine. Pericardial effusion attacks and nodules in the spleen disappeared. The patient had a mild pleural effusion attack which has not yet repeated. CONCLUSION: Mifamurtide, which activates macrophages, can also activate immunity with a stand by effect and cause a hypersensitivity reaction.


Asunto(s)
Neoplasias Óseas , Osteosarcoma , Derrame Pleural , Acetilmuramil-Alanil-Isoglutamina/análogos & derivados , Humanos , Fosfatidiletanolaminas , Derrame Pleural/inducido químicamente
16.
Ulus Travma Acil Cerrahi Derg ; 15(1): 7-11, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19130332

RESUMEN

BACKGROUND: Uncontrolled hemorrhage is the leading cause of fatality. The aim of this study was to evaluate the effect of zeolite mineral (QuikClot - Advanced Clotting Sponge [QC-ACS]) on blood loss and physiological variables in a swine extremity arterial injury model. METHODS: Sixteen swine were used. Oblique groin incision was created and a 5 mm incision was made. The animals were allocated to: control group (n: 6): Pressure dressing was applied with manual pressure over gauze sponge; or QC group (n: 10): QC was directly applied over lacerated femoral artery. Mean arterial pressure, blood loss and physiological parameters were measured during the study period. RESULTS: Application of QC led to a slower drop in blood pressure. The control group had a significantly higher increase in lactate within 60 minutes. The mean prothrombin time in the control group was significantly increased at 60 minutes. The application of QC led to decreased total blood loss. The QC group had significantly higher hematocrit levels. QC application generated a significant heat production. There were mild edematous and vacuolar changes in nerve samples. CONCLUSION: According to the physiological parameters, we observed that zeolite tends to reduce blood loss, however could not stop bleeding completely. We believe that further clinical trials are needed to conclude that zeolite could be used in the routine practice.


Asunto(s)
Modelos Animales de Enfermedad , Hemorragia/tratamiento farmacológico , Hemostáticos/uso terapéutico , Zeolitas/uso terapéutico , Administración Tópica , Animales , Vendajes , Presión Sanguínea/efectos de los fármacos , Arteria Femoral/lesiones , Hematócrito , Hemorragia/terapia , Distribución Aleatoria , Organismos Libres de Patógenos Específicos , Tasa de Supervivencia , Porcinos
17.
Urology ; 116: 231.e1-231.e5, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-29505856

RESUMEN

OBJECTIVE: To compare the barbed polyglyconate suture (BPS) with 2 commonly used conventional sutures, this prospective randomized trial was designed. The sutures applied in the urinary collecting system, in terms of long-term histopathologic and macroscopic suture material features. MATERIALS AND METHODS: Eight female and 6 male New Zealand rabbits were included in the study. Each animal served as its own control and was subjected to cystotomy. Watertight running cystorrhaphies were performed using 3 different sutures in a randomized fashion, namely Monocryl, Vicryl, and V-Loc 90. Seven animals were sacrificed after the third and 7 after the sixth week. Macroscopic and histopathologic examinations were performed. Tissue reaction, like inflammation and fibrosis, around the sutures were evaluated. Friedman and Wilcoxon signed ranks test was used for the statistical analysis. RESULTS: The BPS demonstrated no adhesion. However, in the six-week group, stone formation was recorded on 4 BPS and 1 Vicryl thread, a difference being statistically significant (P = .039). Additionally, in the third- and in the sixth-week group, 1 (P = .368) and 3 (P = .050) BPS threads migrated, respectively. The histopathologic analysis revealed less inflammation and fibrosis associated with the BPS thread in both the third and the sixth-week groups (P = .010 and P = .002, respectively). CONCLUSION: The BPS appears to be superior to conventional sutures in terms of local inflammation and fibrosis. However, suture migration and stone formation following collecting system closure could be potential predicaments.


Asunto(s)
Cistotomía , Dioxanos , Poliésteres , Poliglactina 910 , Suturas , Vejiga Urinaria , Animales , Femenino , Masculino , Conejos , Dioxanos/efectos adversos , Fibrosis , Poliésteres/efectos adversos , Poliglactina 910/efectos adversos , Distribución Aleatoria , Suturas/efectos adversos , Vejiga Urinaria/patología , Vejiga Urinaria/cirugía
18.
Turk Patoloji Derg ; 34(1): 41-48, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-28984336

RESUMEN

OBJECTIVE: As there is continuing disagreement among the observers on the differential diagnosis between the epithelial changes/lesions and neoplasms of the gallbladder, this multicentre study was planned in order to assess the rate of the epithelial gallbladder lesions in Turkey and to propose microscopy and macroscopy protocols. MATERIAL AND METHOD: With the participation of 22 institutions around Turkey that were included in the Hepato-Pancreato-Biliary Study Group, 89,324 cholecystectomy specimens sampled from 2003 to 2016 were retrospectively evaluated. The numbers of adenocarcinomas, dysplasias, intracholecystic neoplasms/adenomas, intestinal metaplasias and reactive atypia were identified with the review of pathology reports and the regional and countrywide incidence rates were presented in percentages. RESULTS: Epithelial changes/lesions were reported in 6% of cholecystectomy materials. Of these epithelial lesions, 7% were reported as adenocarcinoma, 0.9% as high-grade dysplasia, 4% as low-grade dysplasia, 7.8% as reactive/regenerative atypia, 1.7% as neoplastic polyp, and 15.6% as intestinal metaplasia. The remaining lesions (63%) primarily included non-neoplastic polypoids/hyperplastic lesions and antral/pyloric metaplasia. There were also differences between pathology laboratories. CONCLUSION: The major causes of the difference in reporting these epithelial changes/lesions and neoplasms include the differences related to the institute's oncological surgery frequency, sampling protocols, geographical dissimilarities, and differences in the diagnoses/interpretations of the pathologists. It seems that the diagnosis may change if new sections are taken from the specimen when any epithelial abnormality is seen during microscopic examination of the cholecystectomy materials.


Asunto(s)
Enfermedades de la Vesícula Biliar/diagnóstico , Enfermedades de la Vesícula Biliar/patología , Neoplasias de la Vesícula Biliar/diagnóstico , Neoplasias de la Vesícula Biliar/patología , Patología Quirúrgica/normas , Humanos , Patología Quirúrgica/métodos , Estudios Retrospectivos , Turquía
19.
Balkan Med J ; 34(1): 35-40, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-28251021

RESUMEN

BACKGROUND: Intraabdominal adhesions remain a significant cause of morbidity and mortality. Moreover, intraabdominal adhesions can develop in more than 50% of abdominal operations. AIMS: We compared the anti-adhesive effects of two different agents on postoperative adhesion formation in a cecal abrasion model. STUDY DESIGN: Experimental animal study. METHODS: Forty Wistar albino type female rats were anesthetized and underwent laparotomy. Study groups comprised Sham, Control, Mitomycin-C, 4% Icodextrin, and Mitomycin-C +4% Icodextrin groups. Macroscopic and histopathological evaluations of adhesions were performed. RESULTS: The frequencies of moderate and severe adhesions were significantly higher in the control group than the other groups. The mitomycin-C and Mitomycin-C +4% Icodextrin groups were associated with significantly lower adhesion scores compared to the control group and 4% Icodextrin group scores (p=0.002 and p=0.008, respectively). The adhesion scores of the Mitomycin-C group were also significantly lower than those of the 4% Icodextrin group (p=0.008). CONCLUSION: Despite its potential for bone marrow toxicity, Mitomycin-C seems to effectively prevent adhesions. Further studies that prove an acceptable safety profile relating to this promising anti-adhesive agent are required before moving into clinical trials.


Asunto(s)
Glucanos/farmacología , Glucosa/farmacología , Mitomicina/farmacología , Adherencias Tisulares/prevención & control , Alquilantes/farmacología , Alquilantes/uso terapéutico , Animales , Glucanos/uso terapéutico , Glucosa/uso terapéutico , Icodextrina , Mitomicina/uso terapéutico , Complicaciones Posoperatorias/tratamiento farmacológico , Complicaciones Posoperatorias/patología , Complicaciones Posoperatorias/prevención & control , Ratas , Ratas Wistar/cirugía
20.
J Plast Reconstr Aesthet Surg ; 70(2): 267-273, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27939908

RESUMEN

BACKGROUND: Anastomosis with tissue adhesives is an alternative method for conventional anastomosis. However, this method has several technical challenges. It requires the use of suture to prevent leakage into lumen and precise application onto all surfaces of the anastomosis site. To solve these problems, poloxamer 407 (P 407) was previously used as a stent. In this study, we made heparinized P 407 (h-P 407) as a new formula. We aimed to successfully use h-P 407 as a stent in sutureless anastomosis in a rat abdominal aorta model. METHODS: Sixty Sprague-Dawley rats were used. In the first group, end-to-end anastomoses were performed with suture; in the second and third groups, sutureless anastomoses were performed with 2-octyl cyanoacrylate. As an intraluminal stent, P 407 was used in the second group, and h-P 407 was used in the third group. Anastomosis time was measured. Lumen width, intimal hyperplasia, and foreign body reaction were assessed histologically. Velocity flow rates and vessel diameters were measured radiologically. Burst strength was measured, and the results were statistically evaluated. RESULTS: Sutureless anastomosis was more rapid than conventional anastomosis. Lumen width was narrower in the suture group. Inflammation and foreign body reaction were more severe in the suture group. There was no radiologic and biomechanical difference between the groups. We found that intimal hyperplasia was less in h-P 407 than in P 407. CONCLUSION: h-P407 can be successfully used as an intraluminal stent for sutureless microvascular anastomosis with tissue adhesives.


Asunto(s)
Heparina/farmacología , Poloxámero , Técnicas de Sutura/instrumentación , Suturas , Procedimientos Quirúrgicos Vasculares/métodos , Anastomosis Quirúrgica/métodos , Animales , Anticoagulantes/farmacología , Ratas Sprague-Dawley , Tensoactivos , Adhesivos Tisulares/farmacología , Túnica Íntima/cirugía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA